These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge. Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650 [TBL] [Abstract][Full Text] [Related]
4. Effect of fluticasone propionate aqueous nasal spray on allergen-induced inflammatory changes in the nasal airways of allergic rhinitics following exposure to nitrogen dioxide. Wang JH; Devalia JL; Rusznak C; Bagnall A; Sapsford RJ; Davies RJ Clin Exp Allergy; 1999 Feb; 29(2):234-40. PubMed ID: 10051728 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and onset of action of fluticasone propionate aqueous nasal spray on nasal symptoms, eosinophil count, and mediator release after nasal allergen challenge in patients with seasonal allergic rhinitis. Wang D; Duyck F; Smitz J; Clement P Allergy; 1998 Apr; 53(4):375-82. PubMed ID: 9574879 [TBL] [Abstract][Full Text] [Related]
6. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Rak S; Jacobson MR; Sudderick RM; Masuyama K; Juliusson S; Kay AB; Hamid Q; Löwhagen O; Durham SR Clin Exp Allergy; 1994 Oct; 24(10):930-9. PubMed ID: 7842362 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics. Di Lorenzo G; Gervasi F; Drago A; Esposito Pellitteri M; Di Salvo A; Cosentino D; Potestio M; Colombo A; Candore G; Mansueto S; Caruso C Clin Exp Allergy; 1999 Oct; 29(10):1367-77. PubMed ID: 10520057 [TBL] [Abstract][Full Text] [Related]
9. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. Foresi A; Pelucchi A; Gherson G; Mastropasqua B; Chiapparino A; Testi R J Allergy Clin Immunol; 1996 Aug; 98(2):274-82. PubMed ID: 8757203 [TBL] [Abstract][Full Text] [Related]
10. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis. Weido AJ; Reece LM; Alam R; Cook CK; Sim TC Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780 [TBL] [Abstract][Full Text] [Related]
11. Retrospective study on fluticasone propionate aqueous nasal spray efficacy in patients with allergic rhinitis: evaluation of clinical and laboratory parameters. Ventura MT; Piccinni T; Matino MG; Giuliano G; Di Corato R; Di Napoli P; Tursi A Allergy; 2001 Jan; 56(1):29-34. PubMed ID: 11167349 [TBL] [Abstract][Full Text] [Related]